Global Allergy Diagnostics Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Allergy Diagnostics Market Size

• The global allergy diagnostics market size was valued at USD 6.60 billion in 2024 and is expected to reach USD 15.45 billion by 2032, at a CAGR of 11.22% during the forecast period
• This growth is driven by factors such as rising allergy prevalence, growing awareness and screening efforts, technological advancements in diagnostics, increasing healthcare spending, and environmental and lifestyle changes

Allergy Diagnostics Market Analysis

• Allergy diagnostics refer to the medical tests and procedures used to identify specific allergens responsible for triggering allergic reactions in individuals. These diagnostics are essential for accurate disease identification, treatment planning, and improving patient quality of life
• The allergy diagnostics market is experiencing strong growth, driven by the rising prevalence of allergic diseases, growing awareness and screening initiatives, advancements in diagnostic technologies, increasing healthcare expenditure, and the impact of environmental and lifestyle changes
• North America is expected to dominate the allergy diagnostics market with a share of 45.56%, due to a significant increase in the incidence of respiratory allergic disorders, such as asthma and allergic rhinitis, alongside strong healthcare infrastructure and high awareness levels surrounding allergy testing
• Asia-Pacific is expected to be the fastest growing region in the allergy diagnostics market during the forecast period due to rapid urbanization, significant improvements in healthcare infrastructure, and a rise in allergic conditions due to environmental pollution and lifestyle changes
• Consumables segment is expected to dominate the market with a market share of 65.83% due to high and recurring demand for allergen test kits, reagents, and other diagnostic supplies required for routine allergy testing, which ensures consistent revenue generation and frequent replenishment by diagnostic labs and hospitals

Report Scope and Allergy Diagnostics Market Segmentation

Allergy Diagnostics Market Trends

“Increasing Prevalence of Allergies”

• One prominent trend in the global allergy diagnostics market is the increasing prevalence of allergies
• This trend is driven by the rising exposure to environmental pollutants, changing lifestyles, urbanization, and growing sensitivity to food, drug, and inhaled allergens
  • For instance, World Allergy Organization reports a steady increase in allergic diseases, with conditions such as asthma and food allergies affecting hundreds of millions globally
• The demand for accurate and early allergy diagnosis is growing across hospitals, diagnostic labs, and primary care settings to support timely intervention and better patient outcomes
• As allergic conditions continue to rise, this trend is expected to drive innovation, expand diagnostic access, and fuel sustained market growth

Allergy Diagnostics Market Dynamics

Driver

“Growing Environmental Pollution Levels”

• Growing environmental pollution levels are a key driver of growth in the allergy diagnostics market, as increased exposure to pollutants such as pollen, dust, industrial emissions, and particulate matter contributes to a higher incidence of allergic conditions such as asthma, allergic rhinitis, and skin allergies
• This impact is especially evident in urban and industrialized regions, where poor air quality exacerbates immune responses, leading to greater demand for accurate allergy testing
• As urbanization and climate change continue to worsen air quality, healthcare providers are emphasizing early and precise allergy diagnostics to manage symptoms and prevent complications
• Diagnostic companies are responding by expanding test panels to include a wider range of environmental allergens and developing high-sensitivity assays for improved detection
• The need for timely intervention and rising healthcare costs linked to pollution-induced allergies are further accelerating adoption of diagnostic solutions
  • For instance, Regions with high air pollution, such as parts of Asia and Europe, are seeing increased investment in allergy testing infrastructure and public health initiatives
  • In China, which faces severe air pollution challenges, the government has introduced initiatives to improve healthcare services, including allergy testing, to address growing respiratory and allergy-related health issues
• As pollution levels remain a pressing global concern, this driver is expected to significantly influence innovation and sustained growth in the allergy diagnostics market

Opportunity

“Technological Advancements”

• Technological advancements in diagnostic tools present a significant opportunity for the allergy diagnostics market, enabling the development of more accurate, faster, and cost-effective testing methods
• Diagnostic manufacturers and tech innovators are utilizing advanced technologies such as multiplex assays, AI-driven analysis, and lab-on-a-chip platforms to create next-generation allergy testing solutions that improve sensitivity and efficiency
• This opportunity aligns with the increasing demand for personalized, non-invasive, and real-time allergy testing methods that can be easily integrated into both clinical and home settings
  • For instance, Thermo Fisher Scientific has developed multiplex allergy testing panels that enable the detection of multiple allergens simultaneously, streamlining the diagnosis process
• BioMérieux has introduced automated allergy testing systems that incorporate advanced AI algorithms to improve diagnostic accuracy and reduce human error

• As diagnostic technologies continue to advance, the allergy diagnostics market is poised to benefit from innovations that enable faster and more precise testing, ultimately improving patient outcomes and reducing healthcare costs

Restraint/Challenge

“High Cost of Advanced Allergy Testing Technologies”

• High cost of advanced allergy testing technologies presents a major challenge for the allergy diagnostics market, as the development of sophisticated diagnostic platforms, such as multiplex assays and automated testing systems, requires specialized materials, advanced technology, and precise manufacturing processes
• The need to ensure high diagnostic accuracy, speed, and patient safety drives up both R&D and production expenses, making it difficult for manufacturers to offer affordable solutions at scale
• This challenge is particularly significant for companies targeting cost-sensitive regions and patients without comprehensive insurance coverage, where high testing costs may limit widespread adoption despite increasing demand for allergy diagnostics
  • For instance, Companies such as Thermo Fisher Scientific and BioMérieux invest heavily in R&D and quality manufacturing to produce state-of-the-art allergy testing systems, but these efforts contribute to high unit costs, impacting affordability for end-user
• Without breakthroughs in cost-effective testing technologies and scalable production methods, high costs may restrict broader access to allergy diagnostics, particularly in emerging healthcare markets and lower-income consumer segment

Allergy Diagnostics Market Scope

The market is segmented on the basis of service, tests, allergen, and end-user.

In 2025, the consumables is projected to dominate the market with a largest share in service segment

The consumables segment is expected to dominate the allergy diagnostics market with the largest share of 65.83% in 2025 due to high and recurring demand for allergen test kits, reagents, and other diagnostic supplies required for routine allergy testing, which ensures consistent revenue generation and frequent replenishment by diagnostic labs and hospitals.

The in-vitro tests is expected to account for the largest share during the forecast period in tests market

In 2025, the in-vitro tests segment is expected to dominate the market with the largest market share of 52.04% due to their ability to provide accurate, standardized, and reproducible results without exposing patients to allergens directly, making them safer and more suitable for a broad range of individuals, including those with severe allergy risks.

Allergy Diagnostics Market Regional Analysis

“North America Holds the Largest Share in the Allergy diagnostics Market”

• North America dominates the allergy diagnostics market with a share of 45.56%, driven by a significant increase in the incidence of respiratory allergic disorders, such as asthma and allergic rhinitis, alongside strong healthcare infrastructure and high awareness levels surrounding allergy testing
• U.S. holds a significant share due to its extensive healthcare network, high demand for allergy testing, and adoption of advanced diagnostic technologies such as in-vitro blood tests and multiplex assays
• The region's leadership is further supported by substantial R&D investments and a high number of allergy diagnostics companies, including major players such as Thermo Fisher Scientific, Roche Diagnostics, and Abbott Laboratories, which are focusing on innovative allergy testing solutions
• As the demand for comprehensive allergy testing solutions rises, particularly for food and environmental allergens, North America is expected to maintain its dominant position throughout the forecast period

“Asia-Pacific is Projected to Register the Highest CAGR in the Allergy diagnostics Market”

• Asia-Pacific is expected to witness the highest growth rate in the allergy diagnostics market, driven by rapid urbanization, significant improvements in healthcare infrastructure, and a rise in allergic conditions due to environmental pollution and lifestyle changes
• China holds a significant share due to large-scale investments in healthcare facilities, the adoption of advanced allergy diagnostic technologies, and the growing demand for minimally invasive testing options
• In addition, the increasing focus on personalized healthcare, the need for early diagnosis, and the rise in allergic diseases are expected to accelerate the adoption of allergy diagnostics solutions
• As the region undergoes digital transformation in healthcare and demand for innovative diagnostic tools rises, Asia-Pacific is set to become the fastest-growing region in the global allergy diagnostics market during the forecast period

Allergy Diagnostics Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Thermo Fisher Scientific (U.S.)
• Siemens (Germany)
• Danaher Corporation (U.S.)
• Omega Diagnostics Group PLC (U.S.)
• Minaris Medical America, Inc. (U.S.)
• bioMérieux SA (France)
• Stallergenes Greer (U.K.)
• HOB Biotech Group Corp., Ltd. (China)
• HYCOR Biomedical (U.S.)
• Lincoln Diagnostics, Inc. (U.S.)
• EUROIMMUN Medizinische Labordiagnostika AG (Germany)
• INDOOR Biotechnologies, Inc. (India)
• Dr. Fooke Laboratorien GmbH (Germany)
• R-Biopharm AG (Germany)
• GA Generic Assays GmbH (Germany)
• Tecan Trading AG (Switzerland)
• DST Diagnostische Systeme & Technologien GmbH (Germany)
• ROXALL Medizin GmbH (Germany)
• Astra Biotech GmbH (Germany)

Latest Developments in Global Allergy Diagnostics Market

• In October 2024, ALK launched a new series of allergy skin testing devices, including the AllerTest-1, AllerTest-8, and AllerTest-10, designed to streamline the process of allergy testing and diagnosis. This introduction is likely to strengthen ALK’s position in the global allergy diagnostics market by offering advanced, user-friendly tools that cater to healthcare providers’ growing need for reliable and efficient diagnostic solutions. The expanded product range is expected to enhance accessibility to allergy testing, contributing to market growth
• In October 2024, researchers at the University of Bern, in collaboration with Bern University Hospital, developed a new allergy test aimed at simplifying and enhancing the efficiency of allergy diagnoses. The test has been validated using clinical samples from children and adolescents with peanut allergies. This breakthrough is expected to drive advancements in allergy diagnostic tools, particularly in pediatric care, enhancing early detection and treatment options for allergic conditions, thereby boosting the demand for innovative allergy testing solutions in the market
• In July 2024, AliveDx received the IVDR CE mark for its microarray immunoassay designed to detect specific IgE directed at protein allergens in human serum. This certification marks a significant milestone for the company and positions its product as a viable solution for allergy evaluation. As a result, AliveDx’s approval is expected to drive its market presence in Europe, where regulatory certifications are critical for product adoption, further increasing the availability of innovative diagnostic tools in the allergy testing market
• In June 2024, YorkTest introduced a new initiative to make at-home food sensitivity and allergy testing more accessible to U.S. households. This move is a strategic effort to expand its consumer reach, tapping into the growing trend of at-home healthcare solutions. By empowering individuals to manage their health proactively, YorkTest’s initiative is expected to expand the allergy diagnostics market, particularly in the consumer health segment, where demand for convenient, accessible testing solutions is on the rise
• In May 2023, Metropolis Healthcare Limited launched a novel Component Resolved Diagnostics (CRD) platform in India to diagnose various allergy types. Utilizing artificial intelligence to assist clinicians in making informed decisions, this fourth-generation testing technology is expected to revolutionize the allergy diagnostics market in India. The introduction of AI-driven platforms will enhance diagnostic accuracy and treatment personalization, encouraging wider adoption of advanced allergy testing solutions in emerging markets

SKU-12241